Please check your internet connection and try again.
# Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide
## Overview
Walethmade%2525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520bromide (potassium bromide) is an antiepileptic drug.
## Primary Indications
* Adjunctive therapy in the treatment of seizures in dogs.
* Unapproved for human use.
## Adult Dosing
Not applicable for human use. Dosing in veterinary medicine is typically initiated at 15-30 mg/kg/day divided into 1-2 doses, with titration based on clinical response and serum concentrations.
## Pediatric Dosing
Not applicable for human use. Dosing in veterinary medicine requires careful consideration of pharmacokinetic differences in young animals.
## Dose Adjustments
* **Renal Impairment:** Potassium bromide is renally eliminated; dose reduction may be necessary in patients with renal dysfunction. Serum concentrations should be monitored closely.
* **Hepatic Impairment:** No specific dose adjustment is typically recommended, but caution is advised.
## Contraindications
* Hypersensitivity to bromide.
* Severe renal impairment.
## Adverse Effects
The most common adverse effects are gastrointestinal upset (vomiting, anorexia) and sedation. Other potential adverse effects include polyuria, polydipsia, ataxia, pancreatitis, and skin rash.
## Key Drug Interactions
* **CNS Depressants:** Additive sedative effects may occur.
* **Phenobarbital:** When used concomitantly, phenobarbital serum concentrations may increase, potentially requiring phenobarbital dose reduction.
## Monitoring
* **Therapeutic Drug Monitoring:** Serum bromide concentrations are used to guide dosing and ensure efficacy and safety. Target concentrations vary but are often in the range of 10-20 mg/dL.
* **Renal Function:** Monitor serum creatinine and BUN.
* **Clinical Signs:** Monitor for seizure frequency and adverse effects.
* **Electrolytes:** Monitor electrolytes, particularly chloride, as bromide competes with chloride.
## Clinical Pearls
* Onset of action can be delayed due to slow absorption and elimination, often taking several weeks to reach steady-state serum concentrations.
* Gastrointestinal upset can sometimes be mitigated by administering with food or using enteric-coated formulations if available.
* This drug is primarily used in veterinary medicine and is not approved for human use.
**Disclaimer:** This information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider for any health concerns or before making any decisions related to your health or treatment. Prescribing information may vary and should always be verified with the most current official drug labeling or prescribing guidelines.
